After evening oral administration of 10mg THC + 200mg CBD oil, both point-of-collection oral fluid testing devices showed poor sensitivity at 30 minutes and all tests were negative by 10 and 18 hours post-dose.
Medicinal cannabis patients, employers, law enforcement, and drug testing policymakers
All oral fluid tests negative by 10 hours after oral THC/CBD dosing
What the researchers found
At 30 minutes post-dose, oral fluid THC concentrations varied widely (0-425 ng/mL), and both devices showed poor sensitivity (Securetec: 25%, Drager: 50%). By 10 and 18 hours post-treatment, all participants had THC concentrations below screening cutoffs and all test results were negative. The finding suggests low probability of a positive next-morning test after one-off oral medicinal cannabis use.
Why it matters
Patients using medicinal cannabis for sleep worry about failing workplace or roadside drug tests the next day. This study provides evidence that a standard oral dose is unlikely to produce a positive result the morning after, though it also reveals that current testing devices poorly detect oral cannabis use even shortly after dosing.
The numbers in context
0.5h post-dose: THC range 0-425 ng/mL, mean 48.7 ng/mL. Securetec sensitivity at 0.5h: 25%. Drager sensitivity at 0.5h: 50%. At 10h and 18h: all concentrations below cutoffs, all tests negative.
How the study worked
Randomized, double-blind, crossover trial. 20 adults with insomnia received a single oral dose of 10mg THC + 200mg CBD oil or placebo before sleep. Point-of-collection testing with Securetec DrugWipe 5S (10 ng/mL cutoff) and Drager DrugTest 5000 (25 ng/mL cutoff) at baseline, 0.5h, 10h, and 18h post-dose. LC-MS/MS confirmation at each time point.
What this study cannot tell us
Small sample (n=20). Only one oral dose tested; regular nightly use might produce cumulative detection. Only two testing devices evaluated. The wide variability at 0.5h (0-425 ng/mL) suggests individual pharmacokinetic differences that could affect detection with regular use.
How to read the evidence
Well-designed crossover RCT with gold-standard LC-MS/MS confirmation, though limited by small sample and single-dose design.
When this study was published
2024 study
The bigger picture
The dual finding is important: roadside oral fluid tests poorly detect oral medicinal cannabis (unlike smoked cannabis which deposits THC directly in the mouth), and next-morning tests are very unlikely to be positive. This has implications for both law enforcement and patient reassurance.
Questions still open
- Would daily nightly use of oral cannabis produce detectable next-morning THC? Should oral fluid testing devices have different cutoffs for oral vs inhaled cannabis? How do these results compare to sublingual or edible cannabis products?
Common questions
Will I fail a drug test the morning after taking cannabis oil for sleep?
How well do roadside saliva tests detect oral cannabis?
Read the original research
Detection of Δ9-tetrahydrocannabinol (THC) in oral fluid using two point-of-collection testing devices following oral administration of a THC and cannabidiol containing oil.
Drug testing and analysis, 16(12), 1487-1495
Citation
Suraev, Anastasia; McCartney, Danielle; Kevin, Richard; Gordon, Rebecca; Grunstein, Ronald R; Hoyos, Camilla M; McGregor, Iain S. (2024). Detection of Δ9-tetrahydrocannabinol (THC) in oral fluid using two point-of-collection testing devices following oral administration of a THC and cannabidiol containing oil.. Drug testing and analysis, 16(12), 1487-1495. https://doi.org/10.1002/dta.3658